| Ytd | 16.23% | |
| 1y | -59.71% |
| Open | 2.14 | Prev Close | 2.09 | Low | 2.10 | High | 2.28 | Mkt Cap | 50.72M |
| Vol | 67.31K | Avg Vol | 23.62K | EPS | 0.16 | P/E | 33.75 | Forward P/E | N/A |
| Beta | 1.11 | Short Ratio | 1.96 | Inst. Own | 3.37% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-08 | 50-d Avg | 5.80 | 200-d Avg | 8.47 | 1yr Est | 0.00 |
HUNTSVILLE, Ala., July 22, 2026 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina” or the “Comp
BTIG analyst Thomas Shrader initiates coverage on Serina Therapeutics (AMEX:SER) with a Buy ratin
Gannet BioChem, a leading life sciences manufacturing company, today announced a development partner
US stocks down, Dow falls 300+ points, S&P 500 drops 0.93%, Nasdaq falls 1.25%. Energy shares up
Five Below Inc (FIVE) shares rose 7.2% in pre-market trading after reporting better-than-expected Q4